- AU$4.74bn
- AU$4.86bn
- AU$4.93bn
- 52
- 34
- 100
- 65
Annual balance sheet for Sigma Healthcare, fiscal year end - January 31st, AUD millions except per share, conversion factor applied.
R2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 16.1 | 31.2 | 16.6 | 356 | 14.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 327 | 359 | 337 | 320 | 961 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 702 | 762 | 686 | 913 | 1,377 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 288 | 282 | 291 | 272 | 256 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,185 | 1,248 | 1,174 | 1,378 | 1,831 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 524 | 458 | 477 | 371 | 865 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 671 | 761 | 698 | 507 | 993 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 514 | 487 | 476 | 871 | 838 |
Total Liabilities & Shareholders' Equity | 1,185 | 1,248 | 1,174 | 1,378 | 1,831 |
Total Common Shares Outstanding |